Goldman Sachs named Clover Health as a top pick, noting that the company benefits from Trump-era tariffs.
1 report, 0 independent
Updated Jul 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Goldman Sachs named Clover Health as a top pick, noting that the company benefits from Trump-era tariffs.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Clover Health
U.S. healthcare company
-
Goldman Sachs
American investment bank
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet